102
Participants
Start Date
June 1, 2025
Primary Completion Date
January 1, 2027
Study Completion Date
April 1, 2027
Endoscopic Submucosal Dissection with Systematically mediastinal Lymph Node Dissection
Participants will be evaluated for inclusion criteria and exclusion criteria, and then sign informal consent if desired. Participants will be randomly assigned to the intervention according to a prepared random tables. Participants in the SLND group will receive Endoscopic Submucosal Dissection with systematically mediastinal lymph node dissection
Endoscopic Submucosal Dissection without SLND
Participants will be evaluated for inclusion criteria and exclusion criteria, and then sign informal consent if desired. Participants will be randomly assigned to the intervention according to a prepare random tables. Participants in the non-SLND group will just receive Endoscopic Submucosal Dissection treatment, not undergo Systematically mediastinal Lymph Node Dissection.
Fujian Cancer Hospital
OTHER_GOV